BackBiodelivery Sciences International Overview
Biodelivery Sciences International

Biodelivery Sciences International Return on Equity

Biodelivery Sciences International (BDSI) has a ROE of 45.18%, above the Healthcare sector average of 11.15%.

Get informed when a big investor buys or sells

+ Follow

ROE

45.18%

Return on Equity

45.18%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Biodelivery Sciences International (BDSI) FAQ

As of the most recent data, BDSI shows a ROE of 45.18%. That is above the Healthcare sector average of 11.15%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 11.15%. Biodelivery Sciences International is at 45.18%, which is higher that average. That is roughly 305.1% above the sector mean. Use the comparison chart on this page to see how BDSI stacks up against individual peers as well.

Check the historical chart to see whether BDSI's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Biodelivery Sciences International with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Biodelivery Sciences International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 45.18%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 11.15%, while BDSI is at 45.18%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.